SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-071801
Filing Date
2024-06-14
Accepted
2024-06-14 16:40:23
Documents
23
Period of Report
2024-06-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416858d2_8k.htm   iXBRL 8-K 37393
2 EXHIBIT 1.1 tm2416858d2_ex1-1.htm EX-1.1 277099
3 EXHIBIT 4.1 tm2416858d2_ex4-1.htm EX-4.1 100682
4 EXHIBIT 4.2 tm2416858d2_ex4-2.htm EX-4.2 98332
5 EXHIBIT 5.1 tm2416858d2_ex5-1.htm EX-5.1 11843
6 EXHIBIT 99.1 tm2416858d2_ex99-1.htm EX-99.1 11464
7 EXHIBIT 99.2 tm2416858d2_ex99-2.htm EX-99.2 13478
11 GRAPHIC tm2416858d2_ex5-1img001.jpg GRAPHIC 4038
12 GRAPHIC tm2416858d2_ex5-1img002.jpg GRAPHIC 4066
13 GRAPHIC tm2416858d2_ex99-1img001.jpg GRAPHIC 4127
14 GRAPHIC tm2416858d2_ex99-2img001.jpg GRAPHIC 3594
  Complete submission text file 0001104659-24-071801.txt   886335

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA ganx-20240613.xsd EX-101.SCH 3039
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20240613_lab.xml EX-101.LAB 34240
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20240613_pre.xml EX-101.PRE 22375
26 EXTRACTED XBRL INSTANCE DOCUMENT tm2416858d2_8k_htm.xml XML 3798
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 241045482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)